|Science & Medicine||82|
Point of Inquiry is the Center for Inquiry's flagship podcast, where the brightest minds of our time sound off on all the things you're not supposed to talk about at the dinner table: science, religion, and politics. Guests have included Brian Greene, Susan Jacoby, Richard Dawkins, Ann Druyan, Neil deGrasse Tyson, Eugenie Scott, Adam Savage, Bill Nye, and Francis Collins. Point of Inquiry is produced at the Center for Inquiry in Amherst, N.Y.
September 7th, 2016
Episode 533 of 569 episodes
Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate. Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids. Emily Willingham will also be speaking at the upcoming Women in Secularism conference,September 23-25in Arlington, VA. For more information go towomeninsecularism.org.